Literature DB >> 4038152

The effect of flavone treatment on human otosclerotic ossicle organ cultures.

I Sziklai, O Ribári.   

Abstract

We studied the effect of 7-isopropoxy-isoflavone (Ipriflavone) on the collagen synthesizing activity in human otosclerotic auditory ossicle samples from whole organ cultures during incubation for 96 h, and compared this effect with that found in normal meatal cortical bone. Ipriflavone led to a dose-dependent increase in the collagen synthesizing activity in both the healthy and the otosclerotic bone samples. At the highest Ipriflavone concentration used (50 microM), collagen synthesis increased 6-fold in the cortical bone and 9-fold in the otosclerotic bone, as compared with untreated controls. These findings indicate that the otosclerotic bone cavities are filled in vitro with organic matrix.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038152     DOI: 10.1007/bf00464409

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  13 in total

1.  Structure/activity studies of flavonoids as inhibitors of cyclic AMP phosphodiesterase and relationship to quantum chemical indices.

Authors:  J E Ferrell; P D Chang Sing; G Loew; R King; J M Mansour; T E Mansour
Journal:  Mol Pharmacol       Date:  1979-09       Impact factor: 4.436

2.  Otosclerosis. An electron microscopic and cytochemical study.

Authors:  L G Chevance; P Bretlau; M B Jorgensen; J Causse
Journal:  Acta Otolaryngol Suppl       Date:  1970

3.  Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins.

Authors:  B Peterkofsky; R Diegelmann
Journal:  Biochemistry       Date:  1971-03-16       Impact factor: 3.162

4.  Sodium fluoride for inactivation of the otosclerotic lesion. Present status.

Authors:  G E Shambaugh
Journal:  Arch Otolaryngol       Date:  1969-02

5.  Histopathology of otosclerosis.

Authors:  G T Nager
Journal:  Arch Otolaryngol       Date:  1969-02

6.  The enzymatic mechanism of the otospongiotic disease and NaF action on the enzymatic balance.

Authors:  J R Causse; J Uriel; J Berges; G E Shambaugh; P Bretlau; J B Causse
Journal:  Am J Otol       Date:  1982-04

7.  Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.

Authors:  A Beretz; A Stierle; R Anton; J P Cazenave
Journal:  Biochem Pharmacol       Date:  1982-11-15       Impact factor: 5.858

8.  Cathepsin-B activity in otosclerosis.

Authors:  O Ribári; I Sziklai; J G Kiss; I Sohár
Journal:  Arch Otorhinolaryngol       Date:  1983

9.  Differential sensitivity of osteoclasts and osteoblasts suggests that prostaglandin E1 effects on bone may be mediated primarily through the osteoclasts.

Authors:  G L Wong; B A Kocour
Journal:  Arch Biochem Biophys       Date:  1983-07-01       Impact factor: 4.013

10.  Otosclerosis and otospongiosis: clinical and histological comparisons.

Authors:  C Parahy; F H Linthicum
Journal:  Laryngoscope       Date:  1984-04       Impact factor: 3.325

View more
  5 in total

1.  Ipriflavone: new insights into its mechanisms of action on bone remodeling.

Authors:  M L Brandi; C Gennari
Journal:  Calcif Tissue Int       Date:  1993-02       Impact factor: 4.333

Review 2.  Ipriflavone influences the osteoblastic phenotype in vitro.

Authors:  M L Brandi
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

3.  Ipriflavone improves bone density and biomechanical properties of adult male rat bones.

Authors:  R Civitelli; S H Abbasi-Jarhomi; L R Halstead; A Dimarogonas
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

4.  Histochemical and fine structural study of bone of ipriflavone-treated rats.

Authors:  H Ozawa; H Nakamura; K Irie; M Irie
Journal:  Calcif Tissue Int       Date:  1992       Impact factor: 4.333

5.  Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites.

Authors:  S L Cheng; S F Zhang; T L Nelson; P M Warlow; R Civitelli
Journal:  Calcif Tissue Int       Date:  1994-11       Impact factor: 4.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.